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Abstract
Purpose: We report our experience with endovascular treatment of these lesions, with special consideration of angio­
graphic and clinical outcomes and periprocedural complications.
Material and methods: The analysis included treatment results of 19 patients with 20 aneurysms. The aneurysm size 
ranged from 1.9 to 4.7 mm (mean 3.8, SD 0.7). Clinical examinations with the use of modified Rankin Score and 
angiographic outcomes were evaluated initially postembolisation and at a minimum follow­up of six months.
Results: Initial post­treatment complete and near­complete aneurysm occlusion was achieved in 19 (95%) cases and 
incomplete occlusion in one (5%) case. Imaging follow­up, performed in 17 (89.4%) patients, showed no change 
in the degree of occlusion in 16 (94.1%) patients and coil compaction in one (5.9%). There were no retreatment 
procedures. The procedure­related mortality rate was 5% (1/20) and was associated with intraprocedural aneurysm 
rupture. There was a case of a clinically silent coil prolapse into the parent artery. The clinical follow­up evaluation 
achieved in 17 (89.4%) patients showed no change in clinical status in all followed patients.
Conclusions: Endovascular treatment of small unruptured middle cerebral artery aneurysms is feasible and effective.  
The procedure­related complications are not negligible, especially in terms of the benign natural course of these lesions.
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Introduction
Middle cerebral artery (MCA) aneurysms account for 18­22% 
of all intracranial aneurysms and are the third most 
common location for aneurysmal subarachnoid haemor­
rhage [1,2]. In the case of small unruptured MCA aneu­
rysms, the indication for treatment should be made carefully 
because the risk of rupture of these lesions is very low [3]. 
There are, however, some clinical situations, e.g. an enlarg­
ing aneurysm on repeat imaging, when early treatment is 
recommended [4]. Before an interventional management is 
considered, the natural history of small unruptured aneu­
rysms must be compared with potential procedure­related 
complications. Traditionally, in regard to MCA aneurysms, 
microsurgical clipping has often been the first­line treat­
ment method [5­7]. Although the endovascular coiling of 
MCA aneurysms is controversial, there is increasing inter­
est in treating these lesions via this approach [6­14]. 
In the literature there are a limited number of studies 
concerning endovascular coiling of small unruptured an­
eurysms [15­17]. In fact, there seems to be no published 
study entirely dedicated to endovascular embolisation 
of small unruptured MCA aneurysms. The purpose of 
the current study is to report our experience with the 
endo vascular coiling of small (< 5 mm) unruptured 
MCA aneurysms, with special regard to immediate and 
long­term radiographic and clinical outcomes and proce­
dure­related complications. 
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Material and methods
Patient population
Between February 2008 and March 2015, 19 patients har­
bouring 20 small (< 5 mm), unruptured MCA aneurysms 
were treated at our centre via endovascular approach. 
There were 15 (78.9%) females and four (21%) males. 
The patients’ ages ranged from 47 to 73 years (mean 57.6, 
SD 6.6). Seven patients underwent standard coil emboli­
sation, and 12 patients underwent stent­assisted coiling. 
All the patients included in the present study were treated 
for the first time via endovascular approach. There were 
no retreatment procedures. For this retrospective study 
Ethics Committee approval and informed patient consent 
were waived.
Aneurysm characteristics 
The aneurysm size, defined as the maximal height of the 
dome, ranged from 1.9 mm to 4.7 mm (mean 3.8, SD 0.7). 
Patient selection for treatment with stents was based only 
on the angioarchitectural characteristics of each aneu­
rysm. Thus, only the wide­neck aneurysms, defined as 
those with aneurysm neck diameter ≥ 4 mm and/or those 
with dome­to­neck ratio < 1.5, were considered for this 
treatment. 
Endovascular techniques
Because all the aneurysms were depicted by computed to­
mography angiography at admission, both conventional 
and rotational digital subtraction angiographies (DSA) 
were performed in every case to evaluate accurately the 
aneurysmal configuration, neck size, and the width and 
height of the aneurysm. All the procedures were per­
formed by experienced interventional radiologists, and 
always after neurosurgical consultation. The patients were 
treated under general anaesthesia. Anti­platelet premedi­
cation, consisting of a 75 mg loading dose of acetylsalicy­
lic acid and an additional 75 mg clopidogrel in the case of 
planned stent­assisted coiling, was performed every day 
for five days before coiling. 
Following selective catheterisation of the aneurysm 
lumen, another microcatheter was placed distally in the 
M2 segment for stent deployment. A neuroform stent 
(Stryker) was advanced over the microguidewire and 
deployed when the precisely targeted location was con­
firmed. Then, the aneurysm was coiled using Stryker 
Detachable Coils in the same session with the help of 
the previously deployed microcatheter. The procedures 
were usually performed in a bi­plane angiography suite. 
Once it was technically feasible, an attempt was made to 
achieve complete occlusion in the first treatment session. 
During the procedures heparinised saline was continu­
ously infused into the arterial line. After embolisation, 
the patient was transferred to the intensive care unit for 
clinical observation and monitoring of medical parame­
ters. At that time, systemic heparin 15,000 IU for the next 
24 hours was administered intravenously to raise the ac­
tivated partial thromboplastin time 2­3 times above nor­
mal values. Patients after uncomplicated treatment were 
typically discharged from hospital on postoperative day 3. 
Antiplatelet therapy consisting of 75 mg acetylsalicylic 
acid was applied postoperatively every day with the in­
tention of administering for the rest of the patient’s life. 
In the case of stent­assisted coiling an additional 75 mg 
of clopidogrel was applied postoperatively every day for 
six weeks. 
Angiographic and clinical analysis
A control angiography was obtained immediately after the 
embolisation and at a minimum follow­up of six months. 
Anatomical results were evaluated using three­class clas­
sification according to Raymond et al. (i.e. complete 
obliteration, residual neck, and residual aneurysm) [18]. 
A lack of contrast filling within the entire aneurysm and 
the residual filling in the aneurysm neck were catego­
rised as complete and near­complete occlusion, respec­
tively, whereas incomplete occlusion was defined as any 
opacification of the aneurysm sac. In cases of complete 
aneurysm obliteration at control angiogram performed 
a minimum of six months after coiling, the patient was 
not followed­up any longer, except for selected cases (e.g. 
endovascular treatment of accompanying cerebral an­
eurysms). Recanalisation was defined as any increase in 
aneurysmal filling at follow­up. Once there was enough 
space for placement of an additional coil, retreatment was 
considered. 
Regarding clinical evaluation, modified Rankin Scale 
(mRS) scores were recorded at discharge from hospi­
tal and during the last angiographic follow­up period. 
Patients who did not undergo control angiography were 
interviewed by telephone if it was possible. 
Detailed patient characteristics as well as outcomes are 
presented in Table 1.
Results
Angiographic results and retreatment
Instant post­embolisation angiogram revealed a complete 
aneurysm occlusion in 18 (90%) cases. A near­complete 
aneurysm occlusion was performed in one case (5%), and 
incomplete occlusion in another one (5%). Primary inad­
equate occlusion of aneurysms resulted from intraproce­
dural aneurysm rupture in one case. In another case, of 
near­complete occlusion, it was impossible to occlude the 
aneurysm with the shortest available coil.
Angiographic follow­up was achieved in 17 (89.4%) 
cases and ranged from six to 78 months, with a mean of 
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19 months. In 16 (94.1%) cases no change in the degree of 
occlusion at initial angiographic follow­up was observed. 
An illustrative example is presented in Figure 1. The re­
canalisation rate was 5.9% (1/17). There were no retreat­
ment procedures.
Clinical results and complications
The procedure­related mortality rate of 5% (1/20 pro­
cedures) was associated exclusively with an event of in­
traprocedural bleeding of the aneurysm. Perforation of 
the aneurysm occurred during insertion of the first coil. 
The embolisation was not continued. Urgently performed 
CT scan revealed massive subarachnoid haemorrhage 
with intraventricular haemorrhage. The patient expired 
as a consequence of delayed cerebral ischaemia associ­
ated with SAH. There was a case of a coil prolapse into 
the parent artery without any adverse neurological con­
sequences. 
Clinical follow­up was achieved in 17 (89.4%) cases 
and performed at 6­78 months (mean 24.1 months) after 
coiling. Analysis showed no change in clinical status in all 
followed patients. 
Discussion
The traditional treatment for MCA aneurysms has been 
microsurgical clipping, because these aneurysms can be 
easily approached surgically and manipulated after splitting 
the Sylvian fissure [19]. Surgical clip ligation in the case 
of MCA aneurysms results in effective and durable an­
eurysm repair with the rates of complete occlusion above 
90% and good neurological outcomes, and this form of 
treatment has been commonly preferred to endovascu­
lar coiling [19,20]. In the literature, how ever, there is no 
randomised, controlled trial that has compared the effi­
cacy and safety of MCA aneurysm treatment between the 
two above­mentioned modalities [7,19­21]. Even on the 
basis of a multicentre, randomised ISAT trial involving 
ruptured intracranial aneurysms, it is impractical to es­
tablish the optimal method of management of MCA an­
eurysms because these lesions were underrepresented in 
Table 1. Patient and aneurysm characteristics, occlusion rates, and outcome for patients with small unruptured middle cerebral artery aneurysms treated 
by coiling
No. Age/
sex
Initial 
symptoms 
Aneu-
rysm 
size 
(mm)
Instant 
aneurysm 
occlusion
Technical 
compli-
cations
Stent-
assisted 
coiling
Occlusion 
at last
 follow-up 
Angiographic 
follow-up 
period 
(months)
mRS at 
discharge
mRS 
at last 
follow-up
Clinical 
follow-up 
period 
(months)
1 73/F Incidental 3.7 Complete None Yes N/A 0 N/A
2 55/F Incidental 4.4 Complete Coil 
prolapse
No Near-complete 20 0 0 20
3 53/F Headache 3.3 Complete None No Complete 6 0 0 48
4 57/M Headache 4.6 Complete None Yes Complete 14 0 0 60
5 61/F Incidental 3.4 Complete None Yes Complete 6 0 0 6
6 56/F Incidental 3.6 Complete None Yes Complete 8 0 0 8
7 60/F Headache 4.5 Complete None Yes Complete 13 0 0 13
8 47/F Headache 4.5 Complete None Yes Complete 7 0 0 7
9 50/M Headache 4.6 Complete None No Complete 6 0 0 6
10 67/F Incidental 4.4 Complete None Yes Complete 6 0 0 6
11 56/F Headache 3.8 Complete None Yes N/A 0 N/A
12 58/F Headache 3.5 Near-complete None No Near-complete 6 0 0 6
13 64/F Incidental 3.6 Complete None Yes Complete 6 0 0 6
14 53/F Incidental 1.9 Complete None Yes Complete 78 0 0 78
15 53/F Incidental 3.5 Complete None Yes Complete 78 0  0 78
16 65/M Incidental 4.6 Complete None No Complete 48 0 0 48
17 60/M Incidental 4.5 Incomplete IAR No N/A 6 N/A
18 55/F Incidental 3.8 Complete None Yes Complete 8 0 0 8
19 47/F Headache 4.7 Complete None No Complete 7 0 0 7
20 57/F Incidental 2.6 Complete None No Complete 7 0 0 7
mRS – modified Ranking Score, IAR- intraoperative aneurysm rupture, N/A – not available
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this study [19,21,22]. The two reported meta­analyses on 
unruptured MCA aneurysms performed by Smith et al. 
and Blackburn et al. showed that the surgical clipping is 
associated with higher occlusion rates compared to coil 
embolisation [20,23]. According to the study by Smith 
et al., the microsurgical procedures yielded slightly low­
er unfavourable clinical outcomes, but in the report of 
Blackburn et al. the functional outcomes did not differ 
significantly between the two groups [20]. 
Although the coil embolisation of MCA aneurysms is 
controversial, there is increasing interest in treating these 
lesions via endovascular approach [6­11]. Advances in 
endovascular techniques such as rotational angiography 
with three­dimensional reconstruction allows improved 
visualisation of MCA aneurysms and arterial branches 
before endovascular treatment [7,20,24]. Development of 
remodelling techniques such as balloons and stents, as well 
as improvement of preventive protocols of anticoagulation, 
have resulted in increased application of endovascular 
therapy of MCA aneurysms [7,20,24]. It is reported that 
in properly selected patients, endovascular coiling of MCA 
aneurysms should be considered, and satisfactory aneu­
rysm occlusion is achieved in 62.5% to 96.8% of patients, 
with a complication rate from 3.8% to 20% [7,8,25,26]. 
One of the fundamental limitations of endovascular 
coiling of MCA aneurysms is the frequently complex 
Figure 1. 53-year-old female patient presented with two small unruptured middle cerebral artery (MCA) aneurysms. A, B) Computed tomography angio-
grams showed two small (< 5 mm) MCA aneurysms. C, D) Control digital subtraction angiography following endovascular coiling, showed the complete 
occlusion of the two aneurysms. Follow-up angiogram (not shown) performed after 78 months confirmed the complete obliteration of the lesions
A
C
B
D
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anatomy of these lesions [7,19]. These aneurysms often 
have wide necks, frequently incorporate one or both M2 
branch vessels, and may have branches originating from 
the base or side wall of the aneurysm [7,19]. Coil emboli­
sation of MCA aneurysms with unfavourable morphology 
may be associated with increased risk of branch occlusion 
[7,19,20,24]. 
In the case of small unruptured aneurysms the indica­
tion for intervention therapy is still under debate. The nat­
ural history of these lesions has not yet been conclusively 
investigated, and there is still uncertainty if coil embolisa­
tion of small unruptured aneurysms significantly reduces 
the incidence of haemorrhage [15­17]. According to the 
prospective ISUIA study published in 2003 the five­year cu­
mulative rupture rate of MCA aneurysms < 7 mm is 0% [3]. 
Other studies on the natural history of unruptured aneu­
rysms revealed a somewhat higher rupture risk in com­
parison to the 2003 ISUIA trial in the case of MCA an­
eurysms, but the risk is still very low [27,28]. The definite 
cut­off size above which the cerebral aneurysms should 
be unequivocally recommended for treatment has not 
yet been determined [15]. Nonetheless, selected patients 
with asymptomatic small aneurysms should be consid­
ered for treatment. These include patients with aneurysm 
growth, younger age, previous subarachnoid haemorrhage 
from another aneurysm, family history of aneurysm in 
first­degree relatives, certain morphological characteris­
tics of aneurysm, or psychological factors [4,29]. When 
deciding how to treat patients with small unruptured an­
eurysms, surgical clipping as well as embolisation proce­
dures may be taken into consideration. In the literature 
there are no studies directly comparing microsurgical clip 
ligation and endovascular embolisation of small asymp­
tomatic unruptured aneurysms [16]. In view of occlusion 
durability, surgical clipping is considered to be applied in 
younger patients with a long life expectancy [29]. In older 
patients coil embolisation might be preferable; however, 
it is doubtful if the risk of treatment in such patients out­
weighs the rupture risk for small unruptured aneurysms 
[29]. Nonetheless, coil embolisation of small unruptured 
aneurysms may be performed with an acceptable occlu­
sion rate and low degree of recurrence [29]. According 
to previous reports the initial complete or near­complete 
occlusion rate of small unruptured aneurysms treated via 
endovascular approach is 94.7­98.6% [15­17]. In compar­
ison to others, small MCA aneurysms are associated with 
lower feasibility of endovascular coiling [16]. Oishi et al. 
reported that the risk of technical failure during endo­
vascular coiling of small (< 10 mm), unruptured cerebral 
aneurysms was highest in MCA aneurysms, with a failure 
rate of 11.1% [16]. The results of our study with the 95% 
rate of the initial complete or near­complete aneurysm 
occlusion showed that small aneurysms on MCA may be 
coiled with satisfactory angiographic outcome. 
The previously reported recanalisation rate during 
endovascular embolisation of small unruptured aneu­
rysms ranges between 2.9% and 9% [17,30,31]. Our re­
sults, with a recanalisation rate of 5.9%, are comparable 
with these studies. It should be noted that two cases of 
complete aneurysm obliteration from our database with 
angiographic follow­up of 48 and 78 months are proof 
that coiling of small unruptured MCA aneurysms may 
have long­term durability. To our knowledge, the present 
two cases of coiled small unruptured MCA aneurysms 
harbour the longest angiographic follow­up compared 
with the literature to date. 
It is obvious that in the case of small unruptured an­
eurysms the risk of treatment­associated complications 
should be lower than the rupture risk of the aneurysms [29]. 
Im et al. presented a 10.1% risk of complications during 
treatment of small unruptured aneurysms, with 0.27% 
morbidity and 0% mortality rate [15]. In their report 
of 500 small unruptured intracranial aneurysms, Oishi 
et al. experienced 38 incidents of complications (7.6%) 
with morbidity and mortality rates of 0.8% and 0.2%, 
respectively [16]. The 5% risk of procedure­related mor­
tality presented in the current study seems to be quite 
high, especially considering the low rupture rate of small 
MCA aneurysms. This relatively high complication rate 
should be taken into consideration when choosing this 
form of treatment for small unruptured MCA aneurysms. 
Although it is not uniformly established, the coiling of 
small aneurysms in comparison to larger lesions may be 
associated with higher risk of intraprocedural aneurysm 
rupture [17,32,33]. It may result from the more restricted 
space available for movement of a microcatheter within 
the small aneurysm, which results in lesser stabilisation 
of a microcatheter position [17,32,33]. This complication 
may have benign clinical course but also may be associ­
ated with fatal clinical consequences, as was presented in 
the case of aneurysm perforation from the current study 
[17]. In our case the perforation was performed with the 
first coil deployed into the aneurysm lumen, and it was 
impossible to stop the bleeding with prompt complete em­
bolisation. This resulted in massive intracranial bleeding 
with subsequent death of the patient. There is a theory 
that a higher rupture rate during coiling of small aneu­
rysms may be associated with a higher stiffness of the in­
itial segment of a coil, i.e. the segment between the tip of 
the microcatheter and that of the coil that contacts the an­
eurysm wall [32]. The so­called bending stiffness of a coil 
is inversely proportional to the length of the coil segment, 
and the stiffness of the initial coil segment is supposed to 
be higher in smaller aneurysms in comparison to larger 
ones. Therefore, the risk of aneurysm perforation with 
a coil may be higher in smaller aneurysms [32]. 
Another adverse event that may take place during an­
eurysm coiling is coil protrusion into the parent artery. 
Coil prolapse may be associated with thromboembolic 
events, and the risk is high, but a stent deployment into 
the parent artery or coil retrieval is generally recommend­
ed for cases of severe protrusions [34]. In the literature, 
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thromboembolism has been the most frequent compli­
cation accompanying MCA aneurysm embolisation, and 
it may have serious clinical sequelae because the MCA 
branches often supply eloquent branches [6,7]. In the case 
of a clinically silent coil prolapse presented in the case 
of our database no interventional treatment was initiated. 
Because the blood flow in the parent artery was main­
tained we decided to treat the patient conservatively with 
aggressive antiplatelet therapy, as was presented in previ­
ous reports [35,36]. The clinical and radiographic course 
of our patient with 20­month follow­up proceeded un­
eventfully, suggesting that the expectant management is 
likely to be a safe treatment option for non­massive coil 
protrusions in small MCA aneurysms. 
A limitation of the current study is its retrospective and 
observational character. There was also a patient­selection 
bias, because all the cases reported in this series were from 
a single institution.
Conclusions
Endovascular treatment of small unruptured MCA aneu­
rysms is feasible with satisfactory angiographic outcome 
and low recurrence rate. However, procedure­related 
complications resulting in severe clinical consequences 
are not negligible and should be taken into consideration, 
especially in terms of benign natural course of these le­
sions.
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